Brief Information of the Compound and Protein
Compound Name |
(1S,10R,11S,14S,15S)-14-(1-{[(1S,3R,5R,6S,8R,10R,11S,13R,15R,16S,18R,20R,21S,23R,25R,26S,28R,30R,31S,33R,35R,36R,37R,38R,39R,40R,41R,42R,43R,44R,45R,46R,47R,48R,49R)-20-(2-{4-[(1S,10R,11S,14S,15S)-5-({2-[3,6-bis(ethylamino)-2,7-dimethyl-9,10-dihydroanthracen-9-yl]phenyl}carbonyloxy)-14-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-trien-14-yl]-1H-1,2,3-triazol-1-yl}ethyl)-15,25,30,35-tetrakis({4-[(1S,10R,11S,14S,15S)-5-({2-[3,6-bis(ethylamino)-2,7-dimethyl-9,10-dihydroanthracen-9-yl]phenyl}carbonyloxy)-14-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-trien-14-yl]-1H-1,2,3-triazol-1-yl}methyl)-10-({4-[(1S,10R,11S,14S,15S)-5-({2-[6-(ethylamino)-3-[(E)-2-(ethylamino)ethenyl]-7-methyl-2-(2-methylprop-1-en-1-yl)-1,4-dihydronaphthalen-1-yl]phenyl}carbonyloxy)-14-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-trien-14-yl]-1H-1,2,3-triazol-1-yl}methyl)-36,37,38,39,40,41,42,43,44,45,46,47,48,49-tetradecahydroxy-2,4,7,9,12,14,17,19,22,24,27,29,32,34-tetradecaoxaoctacyclo[31.2.2.2^{3,6}.2^{8,11}.2^{13,16}.2^{18,21}.2^{23,26}.2^{28,31}]nonatetracontan-5-yl]methyl}-1H-1,2,3-triazol-4-yl)-14-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-trien-5-yl 2-[3,6-bis(ethylamino)-2,7-dimethyl-9,10-dihydroanthracen-9-yl]benzoate
Show/Hide
|
PubChem ID | |||||
|
Compound Structure |
|
|||||
Protein Name |
Estrogen receptor
|
Protein Classification |
Transcription factor
>
Nuclear receptor
>
Nuclear hormone receptor subfamily 3
>
Nuclear hormone receptor subfamily 3 group A
>
Nuclear hormone receptor subfamily 3 group A member 1
|
||||
Uniprot ID | Gene Name | ESR1 |
Table of Molecular Bioactivities Related to the Compound and Protein